These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16202337)

  • 1. [Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal].
    Félix JM; Inês MS; Acosta CM
    Acta Med Port; 2005; 18(1):77-87. PubMed ID: 16202337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of oral triptan therapy in Sweden.
    Ramsberg J; Henriksson M
    Cephalalgia; 2007 Jan; 27(1):54-62. PubMed ID: 17212684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eletriptan.
    Sandrini G; Perrotta A; Tassorelli C; Nappi G
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1587-98. PubMed ID: 19929447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
    Tfelt-Hansen P; Iversen HK
    Ugeskr Laeger; 2006 May; 168(19):1850-3. PubMed ID: 16756800
    [No Abstract]   [Full Text] [Related]  

  • 6. [Economic evaluation of acute migraine attack treatment with triptans in Spain].
    Gracia-Naya M; Rejas Gutiérrez J; Latorre Jiménez A; González Garcia P
    Neurologia; 2005 Apr; 20(3):121-32. PubMed ID: 15815947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials.
    Belsey JD
    Curr Med Res Opin; 2004 May; 20(5):659-69. PubMed ID: 15140331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy.
    Kelman L; Von Seggern RL
    Am J Ther; 2006; 13(5):411-7. PubMed ID: 16988536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation.
    Mandema JW; Cox E; Alderman J
    Cephalalgia; 2005 Sep; 25(9):715-25. PubMed ID: 16109054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
    Láinez MJ; Evers S; Kinge E; Allais G; Allen C; Rao NA; Massaad R; Lis K
    Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost effectiveness of treatment with triptanes in Spain].
    Gracia Naya M
    Rev Neurol; 2001 Nov 16-30; 33(10):921-4. PubMed ID: 11785001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    McCormack PL; Foster RH
    Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the 'Act when Mild' study.
    Slof J
    Appl Health Econ Health Policy; 2012 May; 10(3):201-15. PubMed ID: 22320449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness analysis of eletriptan 40 and 80 mg versus sumatriptan 50 and 100 mg in the acute treatment of migraine.
    Wells N; Hettiarachchi J; Drummond M; DPhil M; Carter D; Parpia T; Pang F
    Value Health; 2003; 6(4):438-47. PubMed ID: 12859585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
    Dahlöf CG
    Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eletriptan (relpax) for migraine.
    Med Lett Drugs Ther; 2003 Apr; 45(1155):33-4. PubMed ID: 12719695
    [No Abstract]   [Full Text] [Related]  

  • 20. [Utilizing the strength(s) of rizatriptan 10 mg: cost effective against migraine attacks].
    MMW Fortschr Med; 2009 Mar; 151(13):92-3. PubMed ID: 19504831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.